Clinical Trial Update: EPA for Metastasis Trial 2 [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for EPA in metastatic colorectal cancer with liver metastases; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• EPA (eicosapentaenoic acid) (eicosapentaenoic acid)

Snippet

Sponsor: Mark A Hull, PhD FRCP | Conditions: Liver Metastasis, Colon Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING